AIM at Melanoma - Reshaping the Future Together

Reshaping
the Future Together

Finding the CURE is Personal

Transforming How Clinical Breakthroughs are Achieved

Our global initiatives change the face and the future of melanoma research.

Promoting Change, Locally and Globally

We represent the voice of those affected by melanoma in the US and foster the growth of new advocacy efforts throughout other countries.

View Our Global Efforts »

Reshaping the Future Together

Walking for the CURE

Join our Cause »

Groundbreaking

Research

Working Group

Tissue Bank

Education & Support

Stages of Melanoma

Stage 4

Reshaping the Future Together

Fundraising

AIM Walks & Fun Runs

Donate

AIM Fundraisers & Partner Programs

Sponsor Events

Speak with our Oncology Nurse

AIM offers their Nurse-on-Call Service free of charge to patients & caregivers.

Email Barbara

or call 1-877-246-2635

Search for a Melanoma Specialist

Clinical Trials Matching Service

See Details

Melanoma Education

From risk factors, to melanoma stages, to treatment, and beyond

Learn More »

Innovative Research

Changing the face and future of melanoma research to discover the CURE

Learn More »

Global Engagement & Advocacy

Most influential voice in melanoma, locally and globally

Learn More »

Leading the Way in Legislation

Leading and winning legislative and regulatory change across the country

Learn More »

Melanoma News & Events

News 09/27/2016

Array BioPharma and Pierre Fabre Announce COLUMBUS Phase 3 Study of Encorafenib plus Binimetinib For BRAF-Mutant Melanoma Met Primary Endpoint

Event 09/17/2016

PHOTOS - AIM for the CURE Melanoma Walk & Fun Run - Houston, TX

News 09/16/2016

FDA Approves Modified Dosing Regimen for Bristol-Myers Squibb’s Cancer Treatment Opdivo

News 07/26/2016

U.S. Panel Says Evidence 'Insufficient' to Recommend Skin Cancer Screenings

News 06/07/2016

Long-Term Data from Two Trials Evaluating the Opdivo® (nivolumab) and Yervoy® (ipilimumab) Regimen in Advanced Melanoma Continues to Validate Bristol-Myers Squibb’s Immuno-Oncology Combination Approach

News 06/07/2016

New Data for KEYTRUDA® (pembrolizumab) in Combination with Talimogene Laherparepvec, Dabrafenib Plus Trametinib, or Low-Dose Ipilimumab in Advanced Melanoma Presented at 2016 ASCO Annual Meeting

News 06/07/2016

Novartis Combination Therapy Tafinlar® + Mekinist® Demonstrates Overall Survival Benefit at Three-Year Follow-up in Patients with Advanced Melanoma

News 06/07/2016

Array Presents Full Results from Phase 3 NEMO Study

Event 06/05/2016

PHOTOS - AIM for the CURE Melanoma Walk & Fun Run - Laguna Niguel, CA

Event 06/05/2016

PHOTOS - AIM for the CURE Melanoma Walk & Fun Run - WATERTOWN, NY

Event 05/29/2016

Reshaping
the Future Together

Transforming How Clinical Breakthroughs are Achieved

Promoting Change, Locally and Globally

Reshaping the Future Together

Research

Stages of Melanoma

Fundraising

Speak with our Oncology Nurse

Search for a Melanoma Specialist

Clinical Trials Matching Service

Melanoma Education

Innovative Research

Global Engagement & Advocacy

Leading the Way in Legislation

Melanoma News & Events

Array BioPharma and Pierre Fabre Announce COLUMBUS Phase 3 Study of Encorafenib plus Binimetinib For BRAF-Mutant Melanoma Met Primary Endpoint

PHOTOS - AIM for the CURE Melanoma Walk & Fun Run - Houston, TX

FDA Approves Modified Dosing Regimen for Bristol-Myers Squibb’s Cancer Treatment Opdivo

U.S. Panel Says Evidence 'Insufficient' to Recommend Skin Cancer Screenings

Long-Term Data from Two Trials Evaluating the Opdivo® (nivolumab) and Yervoy® (ipilimumab) Regimen in Advanced Melanoma Continues to Validate Bristol-Myers Squibb’s Immuno-Oncology Combination Approach

New Data for KEYTRUDA® (pembrolizumab) in Combination with Talimogene Laherparepvec, Dabrafenib Plus Trametinib, or Low-Dose Ipilimumab in Advanced Melanoma Presented at 2016 ASCO Annual Meeting

Novartis Combination Therapy Tafinlar® + Mekinist® Demonstrates Overall Survival Benefit at Three-Year Follow-up in Patients with Advanced Melanoma

Array Presents Full Results from Phase 3 NEMO Study

PHOTOS - AIM for the CURE Melanoma Walk & Fun Run - Laguna Niguel, CA

PHOTOS - AIM for the CURE Melanoma Walk & Fun Run - WATERTOWN, NY

PHOTOS - AIM for the CURE Melanoma Walk & Fun Run - Omaha, NE

Please keep me informed.